Perceptive Capital Solutions, a special purpose acquisition company (SPAC) backed by Perceptive Advisors, filed an IPO application with the U.S. Securities and Exchange Commission (SEC) on Tuesdaytodayjackpotnumber, plans to raise up to US$75 million. The company plans to target companies in healthcare or health-care-related industries, particularly in North America or Europe in life sciences and medical technology.

Perceptive Capital Solutions plans to raise $75 million by issuing 7.5 million shares at $10 per share. The offering does not contain warrants or other rights. Based on the proposed deal size, Perceptive Capital Solutions will have a market value of US$97 million.

The company is led by Chairman Joseph Edelman (founder, CEO and portfolio manager of Perceptive Advisors, a life science-focused investment firm) and CEO and Director Adam Stone (Chief Information Officer of Perceptive Advisors).

Perceptive Advisors has supported SPACs several times, most recently ARYA Sciences Acquisition IV (a merger agreement with cryoablation company Adagio Medical) and ARYA Sciences Acquisition V (liquidation in 2023).

Perceptive Capital Solutions was established in 2024 and plans to list on Nasdaq under the symbol PCSC. The company secretly submitted the application on April 16, 2024. Jefferies was the only bookkeeper for the transaction.